🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, fixed-sequence study to evaluate the effect of capiv...
Status
Completed
Location
Research Site
Start Date
2021-10-15
Trial ID
NCT04958226
Treatments Being Tested
This is an open-label randomized phase II study in estrogen receptor positi...
Status
Recruiting
Location
Department of Oncology, National Taiwan University Hospital
Start Date
2023-01-17
Trial ID
NCT05720260
Treatments Being Tested
This phase II trial studies the effects of the combination of olaparib and ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-09-27
Trial ID
NCT03660826
This is a global, multicenter, open-label, randomized Phase 3 study compari...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2025-08-26
Trial ID
NCT06982521
Treatments Being Tested
The purpose of this study is to learn about how an investigational drug int...
Status
Recruiting
Location
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Start Date
2024-05-31
Trial ID
NCT05593497
Treatments Being Tested
This is a two-part, open-label, randomized, crossover study in healthy subj...
Status
Completed
Location
Research Site
Start Date
2021-07-26
Trial ID
NCT04944771
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and safety of ca...
Status
Active Not Recruiting
Location
Research Site
Start Date
2025-01-07
Trial ID
NCT06764186
Treatments Being Tested
To compare the effect of four and a half days treatment of a range of doses...
Status
Completed
Location
Royal Derby Hospital
Start Date
2014-01
Trial ID
NCT02077569
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of olaparib a...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-11-11
Trial ID
NCT02208375
Treatments Being Tested
The purpose of this study is to assess the effect of capivasertib on the ph...
Status
Completed
Location
Research Site
Start Date
2026-03-19
Trial ID
NCT07241065
Treatments Being Tested